Overview of Zinzino's Revenue Performance
The Zinzino group has reported a remarkable increase in revenue for the recent month, demonstrating a growth of 20% compared to the previous year. The total revenue for January reached SEK 281.2 million, which is an uplift from SEK 233.9 million from the last period. This significant growth indicates a strong performance in the company’s primary sales markets.
Growth Across Sales Markets
In January, Zinzino saw its sales markets collectively boost their revenue by 20%, culminating in SEK 274.1 million. Notably, Faun Pharma contributed a substantial increase in external sales, achieving SEK 7.1 million, up from SEK 4.7 million. This highlights the robust nature of Zinzino's business model, which continues to thrive under changing market conditions.
Revenue Distribution by Regions
The revenue growth reflects diverse performances across various regions, showcasing strength in key markets:
Nordic Region
The Nordics, including countries like Denmark, Finland, and Norway, reported sales of SEK 27.3 million, marking a 5% increase from the previous period.
Central Europe
Central Europe was a standout region with a remarkable increase of 30%, bringing in SEK 90.1 million compared to SEK 69.4 million earlier.
East Europe
East Europe faced a slight decline, with revenues dropping by 14% to SEK 29.4 million, highlighting the challenges in this specific market.
Southern and Western Europe
This region, which includes bustling markets like France and Spain, achieved sales of SEK 46.6 million, growing by 6% over the previous volume.
The Baltics
The Baltic states, including Estonia and Latvia, contributed SEK 10.5 million, indicating a steady growth of 1% from prior reports.
North America
North America displayed a phenomenal growth of 94%, with revenues soaring to SEK 41.3 million from only SEK 21.3 million previously, showcasing the potential of this vast market.
South America
South America proved notable too, showcasing an astounding growth rate of 344%, taking its revenues from SEK 0.9 million to SEK 4.0 million.
Asia-Pacific
In Asia-Pacific, including major markets like Australia and India, revenue increased by 7%, reaching SEK 23.0 million from SEK 21.5 million.
African Markets
Finally, the African market reported SEK 1.9 million in sales, up 27% from previous numbers, indicating growth in developing regions.
Leadership Comments and Future Outlook
Zinzino's CEO, Dag Bergheim Pettersen, emphasized the importance of maintaining momentum in each of these regions to ensure continued growth. The company aims to leverage its strong performance in North America to further penetrate this lucrative market. There are plans to explore new product lines and marketing strategies, enhancing customer engagement and brand loyalty across all markets.
Key Contacts
If you would like further insights or have specific inquiries about Zinzino's operations, you can reach out to:
Dag Bergheim Pettersen, CEO, +47 (0) 932 25 700
Fredrik Nielsen, CFO, +46 (0) 707 900 174
Frequently Asked Questions
What was the revenue increase for Zinzino in January 2026?
Zinzino reported a 20% revenue increase in January 2026, amounting to SEK 281.2 million.
Which region saw the highest revenue growth?
North America experienced the highest growth, with a 94% increase in revenue.
How did Faun Pharma perform in comparison to last year?
Faun Pharma’s external sales grew from SEK 4.7 million to SEK 7.1 million.
What challenges did East Europe face?
East Europe saw a revenue decline of 14%, indicating specific market challenges.
How can I contact Zinzino for more information?
You can contact Zinzino directly through their CEO or CFO for inquiries regarding their operations.
